Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
44.55
-0.45 (-1.00%)
At close: Mar 6, 2026, 4:00 PM EST
44.30
-0.25 (-0.56%)
After-hours: Mar 6, 2026, 7:36 PM EST
Sanofi Employees
Sanofi had 74,846 employees as of December 31, 2025. The number of employees decreased by 8,032 or -9.69% compared to the previous year.
Employees
74,846
Change (1Y)
-8,032
Growth (1Y)
-9.69%
Revenue / Employee
$732,842
Profits / Employee
$122,564
Market Cap
106.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 74,846 | -8,032 | -9.69% |
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | 100,409 | -3,817 | -3.66% |
| Dec 31, 2018 | 104,226 | -2,340 | -2.20% |
| Dec 31, 2017 | 106,566 | -293 | -0.27% |
| Dec 31, 2016 | 106,859 | -2,230 | -2.04% |
| Dec 31, 2015 | 109,089 | 1,702 | 1.58% |
| Dec 31, 2014 | 107,387 | -4,741 | -4.23% |
| Dec 31, 2013 | 112,128 | 154 | 0.14% |
| Dec 31, 2012 | 111,974 | -1,745 | -1.53% |
| Dec 31, 2011 | 113,719 | 12,144 | 11.96% |
| Dec 31, 2010 | 101,575 | -3,292 | -3.14% |
| Dec 31, 2009 | 104,867 | 6,654 | 6.78% |
| Dec 31, 2008 | 98,213 | -1,282 | -1.29% |
| Dec 31, 2007 | 99,495 | -794 | -0.79% |
| Dec 31, 2006 | 100,289 | 3,108 | 3.20% |
| Dec 31, 2005 | 97,181 | 742 | 0.77% |
| Dec 31, 2004 | 96,439 | 63,353 | 191.48% |
| Dec 31, 2003 | 33,086 | 650 | 2.00% |
| Dec 31, 2002 | 32,436 | 1,922 | 6.30% |
| Dec 31, 2001 | 30,514 | 1,314 | 4.50% |
| Dec 31, 2000 | 29,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Novo Nordisk | 69,505 |
| GSK plc | 68,629 |
| AbbVie | 57,000 |
| Bristol-Myers Squibb Company | 32,500 |
SNY News
- 16 hours ago - Need Growing EPS And Dividends? Prescribe Sanofi - Seeking Alpha
- 1 day ago - Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director - GlobeNewsWire
- 2 days ago - Press Release: Filing of an amendment to the French "Document d'Enregistrement Universel" containing the Annual Financial Report - Benzinga
- 2 days ago - Press Release: Filing of an amendment to the French “Document d'Enregistrement Universel” containing the Annual Financial Report - GlobeNewsWire
- 2 days ago - Sino Biopharmaceutical (SBHMY) Strikes $1.53B Deal with Sanofi for Cancer Drug - GuruFocus
- 3 days ago - Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters
- 3 days ago - Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer - Nasdaq
- 4 days ago - 4 Large-Cap Pharma Stocks to Watch as Industry Recovery Gains Steam - Nasdaq